Abstract
Human neutrophils possess a superoxide (O inf2 sup− )-forming NADPH oxidase which is activated by the chemoattractants, N-formyl-l-methionyl-l-leucyl-l,-phenylalanine (fMet-Leu-Phe), complement C5a, platelet-activating factor and leukotriene B4. We studied the roles of cAMP and cGMP in the regulation of O inf2 sup− formation using the cell-permeant analogues of cyclic nucleotides, N6,2′-O-dibutyryl adenosine 3′:5′-cyclic monophosphate (Bt2cAMP) and N2,2′-O-dibutyryl guanosine 3′:5′-cyclic monophosphate (Bt2cGMP). Bt2cAMP inhibited O inf2 sup− formation induced by these chemoattractants to similar extents. Bt2cGMP as low as 10 μmol/l significantly inhibited O inf2 sup− formation induced by fMet-Leu-Phe at a submaximally effective concentration (50 nmol/1), and Bt2cGMP was more effective in diminishing O inf2 sup− formation than Bt2cAMP. In contrast, Bt2cGMP did not affect O inf2 sup− formation induced by fMet-Leu-Phe at a maximally effective concentration (1 μmol/l). Bt2cGMP (0.1 and 1 mmol/l) enhanced O inf2 sup− formation induced by 0.1 μmol/l C5a by 23% and 49%, respectively, and Bt2cGMP antagonized inhibition of O inf2 sup− formation caused by Bt2cAMP. Bt2cGMP inhibited platelet-activating factor-induced O inf2 sup− formation to a lesser extent than Bt2cAMP and had no effect on that induced by leukotriene B4. Bt2cAMP and Bt2cGMP had no effect on O inf2 sup− formation induced by NaF, γ-hexachlorocyclohexane, phorbol myristate acetate, A 23187 and arachidonic acid. Our data suggest that: 1. Bt2cAMP generally inhibits chemoattractant-stimulated O inf2 sup− formation. 2. Bt2cGMP inhibits fMet-Leu-Phe- and platelet-activating factor-stimulated O inf2 sup− formation but potentiates C5a-induced O inf2 sup− formation. 3. The lack of effect of cyclic nucleotides on O inf2 sup− formation induced by agents other than receptor agonists indicates that cAMP and cGMP modulate early steps of the signal transduction processes initiated by chemoattractants.

This publication has 30 references indexed in Scilit: